ACUPHARMA ApS: Financial statements 2024
CVR: 10072956
Source: annual report 2024, Danish Business Authority
01/10/2023 – 30/09/2024
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 610,216 and a net result of DKK -258,766 compared with DKK 153,246 the year before. That is a decrease of 45.9% compared with the year before. Equity in the 2024 report amounted to DKK -396,873. The company had 2 employees in the financial year.
- Gross Profit
- DKK 610,216
- Profit/Loss
- DKK -258,766
- Equity
- DKK -396,873
- Total Assets
- DKK 1,819,587
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 610 t. | -259 t. | -397 t. | 2 |
| 2023 | - | 1.1 mio. | 153 t. | -138 t. | 2 |
| 2022 | - | 778 t. | -450 t. | -291 t. | 2 |
| 2021 | - | 1.2 mio. | 6 t. | 158 t. | 3 |
| 2020 | - | 1.4 mio. | -235 t. | 152 t. | 3 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ACUPHARMA ApS has published its annual report for 2023. Gross profit came to DKK 1,128,195, and the net result was DKK 153,246.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.